Key statistics
On Monday, Cytek Biosciences Inc (CTKB:NSQ) closed at 3.40, 43.46% above the 52 week low of 2.37 set on May 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.55 |
---|---|
High | 3.62 |
Low | 3.40 |
Bid | 3.20 |
Offer | 3.65 |
Previous close | 3.55 |
Average volume | 1.50m |
---|---|
Shares outstanding | 126.66m |
Free float | 117.41m |
P/E (TTM) | -- |
Market cap | 449.64m USD |
EPS (TTM) | -0.0864 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
More ▼
- Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
- Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
- Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
- Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
- Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
- Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
More ▼